ISebe leHlabathi

Ekuqaleni kukaMatshi, iNational Medical Products Administration yavuma iJaypirca® (pirtobrutinib) ukuba inyangwe abantu abadala abane-chronic lymphocytic leukemia (CLL) okanye i-small lymphocytic lymphoma (SLL) abaye bafumana ubuncinane unyango olunye lwangaphambili, kuquka ne-Bruton's tyrosin...Funda ngokugqithisileyo»

Iindaba ezinomdla zisandula ukuvela kwiZiko loVavanyo lwaMayeza (i-CDE) le-National Medical Products Administration yaseTshayina: uvavanyo lweklinikhi lwe-KSD-101 Injection, oluphuhliswe yiHensen Bio, luvunyiwe. Ukusetyenziswa okubonisiweyo kukwi-"EBV-associated hematological tumors" ezi...Funda ngokugqithisileyo»

Kutshanje, i-China National Medical Products Administration (NMPA) ivumile uphawu olutsha lweBireociclib, iyeza elitsha leKlasi 1 elenziwe ngokuzimeleyo yiXuanzhu Biopharmaceutical. Olu khetho lutsha lusetyenziswa kunye ne-aromatase inhibitor njengonyango lokuqala lwe-endocrine...Funda ngokugqithisileyo»

Ngomhla wama-28 kuFebruwari, ngo-2026, i-National Medical Products Administration (NMPA) yavuma ngokusesikweni ukuthengiswa kwe-JMKX001899 sulfate kunyango lwabantu abadala abane-KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC) abaye bafumana ubuncinane unyango olunye lwangaphambili. JMKX00189...Funda ngokugqithisileyo»

Ngomhla we-13 kweyoMdumba, ngo-2026, iZiko loVavanyo lwaMayeza (i-CDE) le-National Medical Products Administration yaseTshayina libhengeze ukuba iipilisi ze-GFH375 zibandakanyiwe kwi-Breakthrough Therapy Designation yokunyanga izigulana ezine-KRAS G12D-mutant non-small cell lung cancer (NSCLC) ezi ...Funda ngokugqithisileyo»

Ngomhla we-12 kweyoMdumba, ngo-2026, iZiko loVavanyo lwaMayeza (i-CDE) le-National Medical Products Administration yaseTshayina labhengeza ngomhla wesi-4 kweyoMdumba ukuba i-ENHERTU® (trastuzumab deruxtecan) icetyisiwe ukuba ifakwe kwiNkqubo yoNyango lokuPhumelela ukuze isetyenziswe njengonyango oluncedisayo kwizigulana zabantu abadala abane-HER2...Funda ngokugqithisileyo»

ISebe leMicimbi yeHlabathi leSibhedlele i-Oncology saseBeijing South Region liyazingca ngokubonelela izigulane zamazwe ngamazwe ngokufikelela kunyango lomhlaza oluphambili, oluquka i-Boron Neutron Capture Therapy (BNCT) – unyango olutshintshileyo olusele lutshintshe ubomi. Ubungqina bokwenyani: Uhambo lukaNksk. Wu ngo-2022...Funda ngokugqithisileyo»

Ngomhla wesi-9 kuFebruwari, ngo-2026, iwebhusayithi esemthethweni yeZiko loVavanyo lwaMayeza (i-CDE) le-National Medical Products Administration (i-NMPA) yabhengeza ukuba i-ZL-1310 yokujova, i-DLL3-target antibody-drug conjugate (ADC) entsha, icwangciselwe ukunikwa iBreakthrough Therapy Designation. Njengelungu...Funda ngokugqithisileyo»

Kuwo wonke umguli ohamba umgama omde ukuya kufuna unyango lwethu, siyaqonda nzulu: into oyizisayo ayizongxelo zonyango ezintsonkothileyo kuphela kodwa kunye nokuthembana nethemba losapho lwakho lonke. KwiSebe leZibhedlele ze-Oncology zaseBeijing South Region International, sibona amabali anjalo yonke imihla—ho...Funda ngokugqithisileyo»

Njengoko sijongene nomceli mngeni wonyango lomhlaza we-colorectal one-HER2-positive, siyaqonda ngokupheleleyo umnqweno wakho ongxamisekileyo wokhetho lonyango olusebenzayo noluphucukileyo. Namhlanje, sizisa iindaba ezikhuthazayo ezivela kwicandelo le-oncology laseTshayina. **Unyango oluPhambili Lufikeleleka: I-SHR-A1811 Ibonisa Ukungafani...Funda ngokugqithisileyo»

Kutshanje, i-National Medical Products Administration yaseTshayina ivumile ngokusesikweni unyango oludibeneyo lwe-Anlotinib Hydrochloride kunye nePenpulimab yiChia Tai Tianqing kunyango lokuqala lwe-hepatocellular carcinoma ephucukileyo. Oku kubonisa uphawu lweshumi oluvunyiweyo lwe-Anlotinib Hyd...Funda ngokugqithisileyo»

Kutshanje, icandelo lonyango lomhlaza eTshayina lifikelele kwinqanaba elibalulekileyo. Ngomhla wesi-7 kweyoMqungu, ngo-2025, i-National Medical Products Administration yamkele ngokusesikweni ichiza elitsha i-SHR-1701 ukuba lisetyenziswe kwimarike. Liboniswa xa lidibene ne-chemotherapy njengonyango lokuqala lwe-l...Funda ngokugqithisileyo»